New Key Statistics Module, Z-Score and F-Score
LSE:GSK Key Ratios
Market Cap £ M | 65,426.54 |
Enterprise Value £ M | 79,386.54 |
P/E(ttm) | 16.37 |
PE Ratio without NRI | 14.76 |
Forward PE Ratio | 9.16 |
Price/Book | 4.55 |
Price/Sales | 2.10 |
Price/Free Cash Flow | 12.71 |
Price/Owner Earnings | 9.78 |
Payout Ratio % | 0.54 |
Revenue (TTM) £ M | 31,446.00 |
EPS (TTM) £ | 0.98 |
Beneish M-Score | -2.67 |
10-y EBITDA Growth Rate % | 1.10 |
5-y EBITDA Growth Rate % | 1.00 |
y-y EBITDA Growth Rate % | -9.30 |
EV-to-EBIT | 13.93 |
EV-to-EBITDA | 9.82 |
PEG | 14.76 |
Shares Outstanding M | 4,078.96 |
Net Margin (%) | 12.83 |
Operating Margin % | 19.90 |
Pre-tax Margin (%) | 15.96 |
Quick Ratio | 0.54 |
Current Ratio | 0.82 |
ROA % (ttm) | 6.81 |
ROE % (ttm) | 29.93 |
ROIC % (ttm) | 11.06 |
Dividend Yield % | 3.74 |
Altman Z-Score | 1.88 |
LSE:GSK Number of Guru Trades
LSE:GSK Volume of Guru Trades
Gurus Latest Trades with LSE:GSK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
LSE:GSK is held by these investors
Total 1